S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Baker Bros Advisors/Q3 2023

Baker Bros Advisors

Periodo: Q3 2023 · Depositato: 2023-11-14
Vedi su SEC EDGAR
AUM
$17.35B
Valore totale del portafoglio
Posizioni
101
Titoli dichiarati
Prima Posizione
SGEN
54.5% $9.45B
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2023-11-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
SGENSeagen Inc.$9.45B54.48%
54.5%
ONCBeiGene, Ltd.$2.10B12.10%$178.50$297.65+66.8%
12.1%
INCYIncyte Corporation$2.09B12.05%$58.06$116.86+101.3%
12.1%
ACADACADIA Pharmaceuticals Inc.$893.3M5.15%$21.47$25.97+21.0%
5.2%
BMRNBioMarin Pharmaceutical Inc.$337.1M1.94%$87.08$58.99-32.3%
1.9%
MDGLMadrigal Pharmaceuticals, Inc.$225.7M1.30%$143.36$528.10+268.4%
1.3%
RYTMRhythm Pharmaceuticals, Inc.$153.7M0.89%$22.10$114.17+416.6%
0.9%
ROIVRoivant Sciences Ltd.$138.7M0.80%$10.52$35.13+233.9%
0.8%
IMCRImmunocore Holdings plc$130.8M0.75%$48.02$32.50-32.3%
0.8%
Invitae Corporation$130.4M0.75%
0.8%
AKROAkero Therapeutics, Inc.$119.8M0.69%
0.7%
ABCLAbCellera Biologics Inc.$95.5M0.55%$4.46$8.11+81.8%
0.6%
BCRXBioCryst Pharmaceuticals, Inc.$90.0M0.52%$6.77$9.84+45.4%
0.5%
REPLReplimune Group, Inc.$78.3M0.45%$15.79$11.58-26.7%
0.5%
TRDAEntrada Therapeutics, Inc.$76.9M0.44%$14.85$7.72-48.0%
0.4%
RVMDRevolution Medicines, Inc.$74.5M0.43%$26.17$189.24+623.1%
0.4%
ARGXargenx SE$74.3M0.43%$487.32$939.68+92.8%
0.4%
SWTXSpringWorks Therapeutics, Inc.$69.4M0.40%
0.4%
KYMRKymera Therapeutics, Inc.$66.0M0.38%$13.57$113.51+736.5%
0.4%
IMTXImmatics N.V.$65.3M0.38%$10.79$9.95-7.8%
0.4%
MRTXMirati Therapeutics, Inc.$61.4M0.35%
0.3%
KNSAKiniksa Pharmaceuticals, Ltd.$48.8M0.28%$16.90$64.53+281.8%
0.3%
RAREUltragenyx Pharmaceutical Inc.$48.7M0.28%$34.80$33.47-3.8%
0.3%
DNLIDenali Therapeutics Inc.$47.3M0.27%$19.79$25.83+30.5%
0.3%
PRLDPrelude Therapeutics Inc.$31.3M0.18%$2.77$4.91+77.3%
0.2%
KODKodiak Sciences Inc.$31.2M0.18%$1.68$38.54+2194.1%
0.2%
NRIXNurix Therapeutics, Inc.$30.5M0.18%$7.23$23.97+231.5%
0.2%
BMEABiomea Fusion, Inc.$29.0M0.17%$12.71$1.41-88.9%
0.2%
IDYAIDEAYA Biosciences, Inc.$28.7M0.17%$25.83$37.65+45.8%
0.2%
CERSCerus Corporation$27.9M0.16%$1.57$3.16+101.3%
0.2%

Attività Trimestre su Trimestre

Q3 2023 vs. Q2 2023

Nuove Posizioni (8)

TickerEmittenteNozionale
IMVTImmunovant, Inc.$16.3M
ARVNArvinas, Inc.$8.1M
TSHATaysha Gene Therapies, Inc.$7.9M
SGMTSagimet Biosciences Inc.$7.2M
Invitae Corporation$6.2M
MIRMMirum Pharmaceuticals, Inc.$6.0M
MORFMorphic Holding, Inc.$4.9M
CELCCelcuity Inc.$4.9M

Posizioni Chiuse (8)

TickerEmittenteNozionale
KDNYChinook Therapeutics, Inc.$55.9M
DICEDICE Therapeutics, Inc.$48.1M
IMGNImmunoGen, Inc.$28.7M
VSTMVerastem, Inc.$9.9M
FATEFate Therapeutics, Inc.$8.0M
ALLOAllogene Therapeutics, Inc.$7.8M
MGNXMacroGenics, Inc.$4.8M
MREOMereo BioPharma Group PLC$4.7M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
CATXXXXXPerspective Therapeutics, Inc.$0.5M+229.4%
DSGNDesign Therapeutics, Inc.$0.4M+200.0%
KALAKALA BIO, Inc.$0.7M+129.4%
EWTXEdgewise Therapeutics, Inc.$2.1M+109.9%
HOOKHOOKIPA Pharma Inc.$1.1M+82.2%
RAREUltragenyx Pharmaceutical Inc.$12.6M+74.5%-3.8%
GLUEMonte Rosa Therapeutics, Inc.$2.8M+62.6%
DNLIDenali Therapeutics Inc.$4.3M+57.5%+30.5%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
TLISTalis Biomedical Corporation$-0.7M-93.3%
ANABAnaptysBio, Inc.$-13.9M-86.3%
NVTAQInvitae Corporation$-9.0M-80.1%
RNAMAvidity Biosciences, Inc.$-7.8M-79.2%
PNTPOINT Biopharma Global Inc.$-8.9M-78.6%
SMMTSummit Therapeutics Inc.$-9.9M-50.2%
ARGXargenx SE$-34.8M-46.0%+92.8%
AFMDAffimed N.V.$-1.8M-32.6%
Torna agli Hedge Fund